Skip to main content

Bladder Scanner

Portable, non-invasive ultrasound measurement of bladder volume from a suprapubic transducer position, often avoiding diagnostic urethral catheterization for post-void residual (PVR) measurement. Devices differ: some reconstruct 3D bladder volume, whereas wearable or continuous models use other ultrasound methods. Useful in urogyn or functional-urology clinics, post-op floors, ICUs, neurology wards and rehab units; scan-guided protocols can reduce unnecessary catheterization.[1][2][7][13]

How It Works​

  • Suprapubic ultrasound estimates volume using the selected device's algorithm; a numeric result still depends on bladder localization, image quality and the clinical context.[13]
  • Real-time pre-scan imaging helps aim some models. Park 2011 compared two different devices and suggested less variability; a 318-patient comparison of BVI 9400 and Prime found that Prime's pre-scan did not improve accuracy, so no universal gain can be promised.[3][14]
  • Some models display automated bladder outlines and live B-mode aiming, as described for the BladderScan i10; these features and contraindications must be checked against the in-service model manual.[13]
  • Examples include historical BladderScan BVI 3000 / 9400 / Prime and current model-specific i10 (Verathon). The wearable Lilium α-200 had intermittent and scheduled measurement modes, but its manufacturer now lists it as discontinued in Japan; do not recommend it as a current purchase or assume US availability.[4][13][15]

Reconstructive-Urology and Urogyn Uses​

PVR measurement — the dominant use​

  • Routine post-void residual in the workup of female SUI, OAB, UUI, mixed UI, voiding dysfunction, recurrent UTI, neurogenic bladder, and underactive bladder.[1][2][5]
  • Voiding-trial protocols after urogyn surgery (post-MUS, sacrocolpopexy, prolapse repair, urethral diverticulectomy, fistula repair). A scanner may help avoid diagnostic catheterization, but the cited Chrouser algorithm addresses adult inpatients generally, not the performance or discharge outcome of each named operation.[6][7]

Post-operative urinary retention​

  • Chrouser 2024 RAND/UCLA expert-consensus algorithm: for adult inpatients with a suitable scanner available, the panel rated catheterization solely to evaluate retention inappropriate; treatment catheterization is a separate decision. If the device is contraindicated or a scan is unreliable, use clinical judgment and an appropriate alternative.[6][13]
  • Volume-threshold framework (Chrouser 2024):[6]
    • Symptomatic at ≥ 300 mL: intermittent catheterization rated appropriate; 100–299 mL was uncertain, not an automatic trigger.
    • Asymptomatic at ≥ 500 mL: catheterization rated appropriate.
    • Asymptomatic at 400–499 mL: uncertain; < 400 mL: inappropriate in this panel. These are inpatient appropriateness ratings, not universal outpatient or postoperative orders.[6]

Catheter-removal protocols​

  • Palese 2010 meta-analysis of three older postoperative studies comparing scan-guided decisions with clinical judgment or routine catheterization reported UTI OR 0.27 (95% CI 0.16–0.47). Only three older postoperative studies were pooled, with different settings, thresholds, training and designs; this is not a procedure-specific 28–35% catheterization reduction or proof that each modern protocol has the same effect.[7]

Neurogenic-bladder PVR surveillance​

  • Ongoing PVR monitoring and timing of clean intermittent catheterization (CIC) in spinal-cord injury, MS, spina bifida, Parkinson's, post-radical-pelvic-surgery neurogenic bladder.[2][5]
  • Wearable or scheduled monitoring may help select patients time catheterization; the Lilium α-200 is a historical example with a scheduled mode, now discontinued in its listed Japanese market. Check current model labeling, local availability and patient-specific validation before home use.[5][15]

Pediatric urology​

  • Non-invasive PVR for the pediatric patient with vesicoureteral reflux, posterior urethral valves, voiding dysfunction, neurogenic bladder (spina bifida).

Clinic-flow uses​

  • "Did the patient empty?" check before discharge from clinic / cystoscopy / urodynamics.
  • Pre-urodynamic baseline PVR.

Accuracy vs Catheterization​

Catheter drainage is a practical comparator, but timing and technique also affect the reference measurement. Scan accuracy varies by device, patient and volume; a small mean bias does not exclude clinically important errors near a threshold:

StudySettingAccuracy
Coombes 1994 (BVI 2500+)50 patients with the second of two historical scannersMean difference 24 mL vs the study's reference (r² = 0.94); not a current-model error limit[8]
Schallom 2020 (Prime Plus)ICU patientsOverall mean bias 3.3 mL vs catheter, but ascites impaired some low-volume decisions; inspect the bladder image and use alternate ultrasound when needed[9]
Zhao 201961 patients, 590 paired readingsMean absolute difference 20.4 mL without augmentation vs 109.2 mL after augmentation; proposed shape correction needs external validation[10]

The inpatient consensus threshold depends on symptoms and confidence in the measurement; do not translate a group-average accuracy statistic into a guarantee at an individual decision boundary.[6][10]

Limitations and Sources of Error​

  • Obesity (BMI ≥ 30). Mavani 2025: median measurement difference 94.2 mL versus 34.8 mL in non-obese patients; intraclass correlation only 0.55 (fair).[11]
  • Ascites or abdominal fluid. Schallom 2020 found less reliable low-volume decisions in some ICU patients with abdominal fluid. BladderScan i10 specifically says not to use it on patients with ascites; choose a suitable alternative, rather than merely accepting an unreliable i10 scan.[9][13]
  • Irregular bladder shape (neurogenic, augmented, hourglass after radiation or prior pelvic surgery, large pelvic mass); correction methods using bladder-deformity indices have been proposed.[10]
  • Post-cystectomy or post-augmentation. Altered geometry may substantially change error (Zhao's augmented subgroup above); validate the in-service device and use a different assessment when needed.[10]
  • Pelvic fluid or masses and altered postsurgical anatomy can create misleading readings. The cited Araklitis study assessed conventional sonographic or fluoroscopic PVR estimates; it does not establish calcified interpubic discs as a portable-suprapubic-scanner error source.[12][13]
  • Operator positioning. Use the device's instructions. The i10 calls for a relaxed supine patient, gel about 3 cm above the pubis, probe orientation and centering of the entire bladder; a partial field of view may underestimate volume.[13]

Advantages Over Catheterization​

  • No urethral instrumentation for the scan itself; fewer unnecessary catheterizations may reduce infection exposure, but Palese's pooled OR does not mean all CAUTI risk is eliminated.[7]
  • No urethral trauma. No stricture risk, no false passage risk, no urethral pain.
  • Less invasive and often more acceptable than catheterization; preserve privacy, consent and trauma-informed communication for the scan itself.
  • Faster. Seconds at the bedside versus minutes for sterile catheter passage.
  • Repeatable. Serial PVR over a voiding trial without escalating CAUTI risk.

Practical Pearls​

  • Follow the selected device's position and aiming instructions; for example, the i10 manual specifies a relaxed supine position, suprapubic gel and a centered full-bladder image.[13]
  • Time the scan relative to voiding. Measure within approximately 5–10 min of voiding for an accurate PVR.
  • Repeat if the value is implausible. Small or large outliers usually reflect operator angulation or patient motion.
  • Reconcile uncertainty at decision boundaries with repeat or 2D ultrasound, clinical examination or catheterization when otherwise indicated; choose a device-appropriate alternative for contraindications (i10: pregnancy, ascites, suprapubic open wounds), and consider difficult-catheter risks after reconstructive surgery.[6][10][13]
  • Build the scanner into the voiding-trial algorithm after urogyn surgery; bladder-scan-first, catheterize only at threshold or for symptoms.[6]
  • Wearable monitoring is model- and access-specific; the α-200's scheduled-mode history is useful, but its manufacturer lists it as discontinued. Assess available alternatives and their instructions rather than treating it as a current default.[15]

Limitations​

  • Not a substitute for urodynamics. It gives volume only; no pressure, no flow, no compliance data.
  • Altered anatomy after cystectomy or augmentation can make standard volume algorithms less reliable; Zhao's augmentation subgroup illustrates a large mean absolute error, not proof of failure in every individual.[10]
  • Reduced reliability in obesity, ascites, irregular bladder and pelvic fluid or masses. Check the particular device's contraindications and use an appropriate alternative or confirmatory method when readings conflict with symptoms.[9][11][13]

See also: Foley Catheter, Intermittent (CIC) Catheter, Three-Way Catheter.

References​

1. Asimakopoulos AD, De Nunzio C, Kocjancic E, et al. "Measurement of post-void residual urine." Neurourol Urodyn. 2016;35(1):55–7. doi:10.1002/nau.22671

2. Panicker JN, Fowler CJ, Kessler TM. "Lower urinary tract dysfunction in the neurological patient: clinical assessment and management." Lancet Neurol. 2015;14(7):720–32. doi:10.1016/S1474-4422(15)00070-8

3. Park YH, Ku JH, Oh SJ. "Accuracy of post-void residual urine volume measurement using a portable ultrasound bladder scanner with real-time pre-scan imaging." Neurourol Urodyn. 2011;30(3):335–8. doi:10.1002/nau.20977

4. Yamaguchi Y, Kamai T, Kobayashi M. "Comparative accuracy of the Lilium α-200 portable ultrasound bladder scanner and conventional transabdominal ultrasonography for postvoid residual urine volume measurement in association with the clinical factors involved in measurement errors." Neurourol Urodyn. 2021;40(1):183–92. doi:10.1002/nau.24530

5. Chancellor MB, Bartolone SN, DeVries EM, et al. "New technology assessment and current and upcoming therapies for underactive bladder." Neurourol Urodyn. 2018;37(8):2932–7. doi:10.1002/nau.23738

6. Chrouser K, Fowler KE, Mann JD, et al. "Urinary retention evaluation and catheterization algorithm for adult inpatients." JAMA Netw Open. 2024;7(7):e2422281. doi:10.1001/jamanetworkopen.2024.22281

7. Palese A, Buchini S, Deroma L, Barbone F. "The effectiveness of the ultrasound bladder scanner in reducing urinary tract infections: a meta-analysis." J Clin Nurs. 2010;19(21–22):2970–9. doi:10.1111/j.1365-2702.2010.03281.x

8. Coombes GM, Millard RJ. "The accuracy of portable ultrasound scanning in the measurement of residual urine volume." J Urol. 1994;152(6 Pt 1):2083–5. doi:10.1016/s0022-5347(17)32314-5

9. Schallom M, Prentice D, Sona C, et al. "Accuracy of measuring bladder volumes with ultrasound and bladder scanning." Am J Crit Care. 2020;29(6):458–67. doi:10.4037/ajcc2020741

10. Zhao L, Liao L, Gao L, et al. "Effects of bladder shape on accuracy of measurement of bladder volume using portable ultrasound scanner and development of correction method." Neurourol Urodyn. 2019;38(2):653–9. doi:10.1002/nau.23883

11. Mavani PT, Ajay PS, Wagner HB, et al. "Defining the reliability of bladder scan in patients with obesity with postoperative urinary retention." Surgery. 2025;185:109547. doi:10.1016/j.surg.2025.109547

12. Araklitis G, Paganotto M, Hunter J, et al. "Can we replace the catheter when evaluating urinary residuals?" Neurourol Urodyn. 2019;38(4):1100–5. doi:10.1002/nau.23963

13. Verathon. BladderScan i10 Operations & Maintenance Manual, 0900-5005 Rev 07, pp 2–4, 41–45; model-specific intended use, contraindications, imaging/aiming and operating instructions.

14. Brouwer TA, van den Boogaard C, van Roon EN, et al. "Non-invasive bladder volume measurement for the prevention of postoperative urinary retention: validation of two ultrasound devices in a clinical setting." J Clin Monit Comput. 2018;32:1117–26. doi:10.1007/s10877-018-0123-6

15. Lilium Otsuka. Lilium α-200 product information and current medical-device lineup; α-200 sales ended in Japan, with IP200/one listed separately.